The above product is not available online.
Please contact us at (888) 245-5000 to order.
Eye Vitamin and Mineral Supplement - with 10 mg Lutein and 2 mg Zeaxanthin
- The antioxidants Lutein and Zeaxanthin are important for rebuilding macular pigment optical density (MPOD)
- Natural source Vitamin E and 25 mg of Zinc
- Includes a proprietary blend of newly researched nutrients, like Taurine, to support eye health
Take 2 capsules per day during a meal, or as directed by your health care professional.
- Serving Size: 2 Capsules
- Servings Per Container: 30
- Amount Per Serving / % Daily Value:
- Vitamin C 500 mg 833%
- Vitamin E 400 IU 1,333%
- Zinc 25 mg 167%
- Copper 1.6 mg 80%
- Lutein (contains FloraGLO®) 10 mg
- Zeaxanthin 2 mg
- Taurine (as L-taurine base) 300 mg
Ingredients: Ascorbic acid, d-alpha tocopheryl acetate, L-taurine, vegetable capsule (hypromellose, titanium dioxide (for color)), zinc amino acid chelate, lutein, silicon dioxide, zeaxanthin, and cupric oxide.
Contains Fish (cod, pollack, haddock, hake, cusk, redfish, sole, flounder), soy and natural source of Vitamin E.
If you are pregnant, nursing, trying to conceive, taking any medications, or have a medical condition, please consult your healthcare practitioner before using this product.
Do not use if inner safety seal is broken.
Keep out of reach of children.
The Age-Related Eye Disease Study (AREDS) demonstrated beneficial effects of oral supplementation with antioxidant vitamins and minerals on the development of advanced age-related macular degeneration (AMD) in persons with at least intermediate AMD (bilateral large drusen with or without pigment changes). Observational data suggest that other oral nutrient supplements might further reduce the risk of progression to advanced AMD.
The primary purpose of Age-Related Eye Disease Study 2 (AREDS2) is to evaluate the efficacy and safety of lutein+zeaxanthin (L+Z) and/or omega-3 long-chain polyunsaturated fatty acid (LCPUFA) supplementation in reducing the risk of developing advanced AMD. The study will also assess the reduction in zinc and the omission of beta-carotene from original AREDS formulation.
